Comerica Bank’s Cytosorbents Corp CTSO Stock Holding History

Comerica Bank’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$2.8K	Buy	4,376 +819	+23%	+$630	﹤0.01%	3490
2025 Q3	$3.32K	Buy	3,557 +557	+19%	+$549	﹤0.01%	3468
2025 Q2	$3.84K	Sell	3,000 -307	-9%	-$308	﹤0.01%	3407
2025 Q1	$3.31K	Sell	3,307 -380	-10%	-$400	﹤0.01%	3389
2024 Q4	$3.35K	Buy	3,687 +889	+32%	+$872	﹤0.01%	3390
2024 Q3	$4.2K	Sell	2,798 -649	-19%	-$712	﹤0.01%	3379
2024 Q2	$2.42K	Buy	3,447 +2,610	+312%	+$2.26K	﹤0.01%	3457
2024 Q1	$795	Buy	837 +318	+61%	+$310	﹤0.01%	3642
2023 Q4	$576	Buy	519 +261	+101%	+$388	﹤0.01%	3665
2023 Q3	$485	Buy	+258	New	+$741	﹤0.01%	3714

Other funds holding CTSO

Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Comerica Bank's CTSO Position: Q4 2025 in Review

Comerica Bank increased its Cytosorbents Corp (CTSO) stake by 23% in Q4 2025, buying an estimated $630 and bringing the position to 4,376 shares worth $2.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3490.

Comerica Bank first reported a position in CTSO in Q3 2023 and has held it in 10 quarters since. The position peaked at $4.2K in Q3 2024. 51 funds tracked by Wall St. Rank hold CTSO as of Q4 2025.

Comerica Bank held 4,376 shares of Cytosorbents Corp worth $2.8K as of Q4 2025.
Comerica Bank bought 819 Cytosorbents Corp shares in Q4 2025, an estimated $630.
Cytosorbents Corp made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3490 holding.
Comerica Bank first reported a position in Cytosorbents Corp in Q3 2023 and has held it in 10 quarters since.
Comerica Bank's Cytosorbents Corp position peaked at $4.2K in Q3 2024.
51 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.